Lumiera Health Inc. (TSXV:NHP) a company specializing in the development and commercialization of natural health products, intends to sell, on a private placement basis, up to 60 million units at a price of $0.01 per unit, for gross proceeds to the company of up to $600,000. The issue price of the units is equal to the closing price of the Lumiera shares on the TSX Venture Exchange on November 17, 2022.

The proceeds from the private placement will be used to support operations, as well as to leverage key opportunities that will accelerate growth.

Each unit will consist of one common share in the capital of the company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share, at an exercise price of $0.05 per share, for a period of three years from the date of issuance.

The company intends to include an acceleration clause in the certificates representing the …

Full story available on Benzinga.com